Drug therapy and hyperprolactinaemia
Drug therapy is the commonest cause of hyperprolactinaemia in clinical practice. It may present with symptoms and signs, or be subclinical. Whilst the phenothiazine and butyrophenone antipsychotic drugs used to be the most common causes of drug-induced hyperprolactinaemia, it is now more often encou...
Gespeichert in:
| Veröffentlicht in: | Adverse drug reaction bulletin 1998-06, Vol.190 (1), p.723-726 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Drug therapy is the commonest cause of hyperprolactinaemia in clinical practice. It may present with symptoms and signs, or be subclinical. Whilst the phenothiazine and butyrophenone antipsychotic drugs used to be the most common causes of drug-induced hyperprolactinaemia, it is now more often encountered in patients taking specific serotonin reuptake inhibitors. |
|---|---|
| ISSN: | 0044-6394 |
| DOI: | 10.1097/00012995-199806000-00001 |